Antonio Leiva

Especialista en Cirugía Ortopédica y Traumatología 

• Facultativo de la Unidad de Acondroplasia y otras Displasias Óseas; 
• Facultativo de la Unidad de Osteosíntesis y Reconstrucción Ósea. 
• Hospital Universitario Virgen de la Victoria, Málaga. Servicio Andaluz de Salud 

Formación de Postgrado: 

• Máster en Patología del Aparato Locomotor, por la Universidad de Jaén. 
• Máster Universitario in New Advancements in Diagnosis, Therapy and Biomedical Research, por la Universidad de Málaga 
• Doctorando en el Programa de Doctorado en Biomedicina, Investigación Traslacional y Nuevas Tecnologías en Salud, por la Universidad de Málaga. 

Miembro de la Unidad de Acondroplasia y Otras Displasias Óseas del Hospital Universitario Virgen de la Victoria, Málaga, con actividad asistencial (clínica y quirúrgica) desde el año 2010 y actividad investigadora entre la que destaca: Sub-Investigator Pro- Validation Study: Validation of an instrument to assess patient (and parent reported) outcomes, in children and adolescents with Achondroplasia (2015 / 2016); Asistente y Ponente en Achondroplasia PRO Tools Expert Meeting. Amsterdam March. Biomarin.(2016); Sub-Investigator Observational study: 111-901 Estudio clínico multicéntrico y multinacional de evaluación sobre pacientes pediátricos con acondroplasia (2016 / 2021); Asistente en Expert Advisory Board Meeting: Considerations in Advancing the treatment of Achondroplasia, Barcelona, Spain (2017); Sub-investigador Clinical Trial: 111-301 - A Phase3 Randomized, Double-Blind,Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN111 in Children with Achondroplasia (2018 / 2019); Sub-investigador Observational study: 111-501 - The Impact of Achondroplasia on Quality of Life, Healthcare Resource Use, Clinical, Socio-economic and Psychosocial state of Individual (2018 / 2019). 

Specialist in Orthopedic Surgery and Traumatology

• Attending physician at the Achondroplasia and Other Bone Dysplasia Unit;
• Attending physician at the Bone Reconstruction and Osteosynthesis Unit.
• Virgen de la Victoria University Hospital, Málaga. Andalusian Health Service

Postgraduate Training:

• Master's Degree in Musculoskeletal Pathology, University of Jaén
• Master's Degree in New Advances in Diagnosis, Therapy and Biomedical Research, University of Málaga
• PhD Candidate in the Doctoral Program in Biomedicine, Translational Research and New Technologies in Health, University of Málaga

Member of the Achondroplasia and Other Skeletal Dysplasia Unit at the Virgen de la Victoria University Hospital in Málaga, with clinical and surgical patient care experience since 2010.  Research activities include: Sub-investigator for the PRO-Validation Study: Validation of an instrument to assess patient (and parent-reported) outcomes in children and adolescents with achondroplasia (2015/2016); Participant and presenter at the Achondroplasia PRO Tools Expert Meeting, Amsterdam, March 2016 (Biomarin); Sub-investigator for the observational study: 111-901 Multicenter, multinational clinical study evaluating pediatric patients with achondroplasia (2016/2021); Participant in the Expert Advisory Board Meeting: Considerations in Advancing the Treatment of Achondroplasia, Barcelona, ​​Spain (2017); Sub-investigator for the clinical trial: 111-301 - A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BMN111 in Children with Achondroplasia (2018/2019); Sub-investigator for the observational study: 111-501 - The Impact of Achondroplasia on Quality of Life, Healthcare Resource Use, and Clinical, Socio-economic, and Psychosocial Status (2018/2019).

Antonio Leiva Gea 
antonioleiva7@yahoo.es